Timothy syndrome (TS) is a rare, multisystem disorder most commonly associated with profound QTc prolongation and cutaneous dysmorphia arising from mutations of the L-type calcium channel. We present a case of a 12-day-old newborn who presented with respiratory distress and cyanosis. Diagnostic workup was notable for multiple cardiac abnormalities, and genetic analysis was consistent with an exon 8 mutation of the CACNA1C gene, which is diagnostic for TS type 2 (atypical TS). This patient presented with a novel constellation of symptoms, without dysmorphic features, and with a more moderate QTc interval. The heterogeneity of phenotypes suggests that this disorder may be characterized by variable expressivity or a spectrum of disease rather than a clearly defined syndrome.
T imothy syndrome (TS) is a rare, multisystem disorder associated with profound QTc prolongation and syndactyly, formally described by Splawski and Timothy et al ( 1 -3 ) . Also known as long-QT syndrome type 8 (LQTS8), TS is caused by gain of function mutations aff ecting the L-type calcium channel CACNA1C gene. Additional syndromic features include facial dysmorphia, cardiac anomalies, and cognitive impairment ( 1 -3 ). TS has been described in less than 50 patients, 5 of whom were noted to have phenotypic/ genotypic variations known as atypical TS ( 4 -6 ) . Th ese patients lack syndactyly and have demonstrated a greater frequency and severity of cardiac symptoms ( 5 ) . Th e paucity of atypical TS cases denotes clear limitations in our ability to produce generalizable conclusions with respect to genotype-phenotype interactions. We describe the youngest documented case of atypical TS in a 12-day-old infant with clinical fi ndings unique from prior cases.
CASE REPORT
Within the patient's fi rst 5 days of life, she experienced intermittent hypoglycemia and hypocalcemia, an episode of bradycardia, desaturation, and abnormal fi ndings on electrocardiography ( Figure 1 ) . Th e echocardiogram showed a patent ductus arteriosus with normal left ventricular systolic function. Th e infant developed severe shortness of breath and episodic fainting spells at 12 days postdelivery. Arterial blood gas showed a pH of 6.9 with lactic acidosis (20.16 mmol/L). Calcium and From Emory University School of Medicine (Philipp, Rodriguez) and Sibley Heart Center Cardiology (Rodriguez), Atlanta, Georgia. Corresponding author: Lucas R. Philipp, 12180 S. Solomon Road, Olathe, KS 66061 (e-mail: Lrphili@emory.edu ).
bicarbonate were given. Th e patient's chest x-ray, lumbar puncture, and all cultures were unremarkable. Th e electrocardiogram showed 2:1 AV conduction (ventricular rate 69 bpm) and a QTc of 636 ms ( Figure 1 ) . Th e brain natriuretic peptide level was 21,000 pg/mL. An echocardiogram showed biventricular systolic dysfunction ( Figure 2 ). Milrinone and esmolol drips were initiated. Th e patient underwent patent ductus arteriosus ligation, and temporary A/V pacing wires were placed. A dual-chamber permanent pacemaker was later implanted via a subxiphoid approach with epicardial right atrial and left ventricular leads. Th e initial mode was DDD 80-210 (activation rate-upper limit of detection), but was revised to DDD 90-210.
Th e results of the GeneDX long QT gene panel were positive for a heterozygous mutation of the CACNA1C gene, demonstrating the Gly406Arg (G406R) mutation-a c.1216 G>A in exon 8. Th is patient had no syndactyly or facial dysmorphia. Her family history was negative for congenital and genetic defects. Th e patient was discharged on day 25 in good condition.
Th e child returned with cardiac arrest with metabolic acidosis (pH 6.78, lactic acid 11.26) 2.5 weeks later. She developed ventricular fi brillation, was defi brillated to resume sinus rhythm, and received magnesium and calcium. She was then bolused with lidocaine and started on a lidocaine drip. Ventricular ectopy and intermittent ventricular tachycardia persisted. Esmolol was started. She had signifi cant hypotension (systolic pressure 30-50 mm Hg) requiring vasopressor support. A repeat echocardiogram showed persistence of her severely depressed biventricular systolic function, and milrinone was added. She continued to have neurologic problems, and a computed tomography scan showed extensive hypoxic ischemic brain injury. After discussion with her parents, care was withdrawn, and the infant died on her 52nd day of life.
DISCUSSION
TS type 1 accounts for most TS cases and is associated with a 100% incidence of cutaneous syndactyly ( 2 ) . Severe cardiac Cardiac arrest refractory to standard intervention in atypical Timothy syndrome (LQT8 type 2) Lucas R. Philipp , BA , and Fred H. Rodriguez III , MD symptoms underlie nearly every diagnosis of TS, including repolarization abnormalities such as a QTc of 480 to 700 ms, 2:1 AV block, and T wave alternans. Structural defects are also common ( 4 ) . Th e leading cause of death is ventricular tachyarrhythmia, which is present in 80% of individuals.
TS type 1 is an autosomal dominant condition, arising from de novo mutations in exon 8a of CACNA1C , which codes for the CaV1.2 protein ( 4 , 7 ). Th is results in a Gly406Arg substitution that alters calcium channel inactivation, leading to excess calcium infl ux and action potential prolongation. Rare cases have described inheritance patterns of somatic mosaicism, which is associated with a milder phenotype ( 2 , 5 , 8 ) . Th e G406R mutation in the CACNA1C gene has also been associated with atypical TS ( 2 , 9 , 10 ). However, atypical TS (TS types 2 and 3) arises from mutations in exon 8 of CACNA1C . Exon 8 is mutually exclusive with exon 8a, exon 8 mRNA being the predominant isoform in most tissues ( 7 ) . In the context of this current understanding of the disorder, the present patient was genotype positive for atypical TS; however, her phenotype was unique. Although a greater incidence and severity of facial dysmorphia has been noted in atypical TS ( 2 ), this infant had normal facial features. Previous studies have suggested that CACNA1C exon 8 TS genotypes are associated with a more extreme prolongation of QTc in aff ected individuals, ranging between 620 and 730 ms ( 4 , 5 , 9 ) . A proposed explanation is the predominance of exon 8 mRNA products in the heart (80%) relative to those of 8a ( 5 ) . Th e QTc of our patient ranged from 487 to 660 ms, with a mean of approximately 550 ms. Th is range falls short of the originally described features of atypical TS ( 2 ), but exceeds the normal rate-corrected ranges by a large margin.
Since our patient was diagnosed at such a young age, we were initially optimistic about her prognosis. We had hoped that with early medical intervention, we would have been able to effectively treat potentially lethal heart rhythms in a prophylactic manner. However, although we successfully placed a cardiac pacemaker in this patient, its function does not address the underlying abnormal cellular pathology within the cardiomyocytes of atypical TS patients. It is of substantial importance to consider the sharp juxtaposition the present case poses to prior reports ( 11 ) . Our patient received standard, evidence-based treatment at an exceptionally early time in the course of her disease. In spite of this, these interventions were not successful.
Th is patient presented with a novel constellation of symptoms, including a more moderate QTc interval and a lack of the facial dysmorphia that has accompanied all prior cases of atypical TS. Th e heterogeneity of phenotypes observed in atypical TS may suggest that the disorder is characterized by variable expressivity or is a spectrum of disease rather than a clearly defi ned syndrome. Most importantly, it has been previously suggested that early medical intervention may be pivotal in preventing early cardiac fatalities in atypical TS. However, pacemaker implantation did not prevent ventricular dysrhythmias in our patient. Th e extent to which this channelopathy disrupts normal electrical activity of the heart may have been previously underestimated, and other potential therapies need to be explored.
